Walleye Trading
ASND icon

Walleye Trading’s Ascendis Pharma A/S ASND Stock Holding History

Walleye Trading’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.6K Sell
300
-8,300
-97% -$1.86M ﹤0.01% 3599
2025
Q4 		$1.83M Buy
8,600
+600
+8% +$124K ﹤0.01% 1967
2025
Q3 		$1.59M Buy
8,000
+300
+4% +$56K ﹤0.01% 1961
2025
Q2 		$1.33M Sell
7,700
-24,300
-76% -$3.96M ﹤0.01% 2001
2025
Q1 		$4.99M Buy
32,000
+21,400
+202% +$3.06M 0.01% 1087
2024
Q4 		$1.46M Sell
10,600
-53,600
-83% -$7.05M ﹤0.01% 1900
2024
Q3 		$9.59M Buy
+64,200
New +$8.67M 0.02% 791
2024
Q2 		– Sell
-800
Closed -$121K – 4251
2024
Q1 		$121K Sell
800
-2,500
-76% -$357K ﹤0.01% 3684
2023
Q4 		$416K Buy
3,300
+1,300
+65% +$130K ﹤0.01% 3228
2023
Q3 		$187K Buy
2,000
+1,800
+900% +$168K ﹤0.01% 3648
2023
Q2 		$17.9K Sell
200
-12,900
-98% -$1.12M ﹤0.01% 4152
2023
Q1 		$1.4M Buy
13,100
+4,200
+47% +$480K ﹤0.01% 1944
2022
Q4 		$1.09M Buy
8,900
+8,500
+2,125% +$987K ﹤0.01% 2156
2022
Q3 		$41K Sell
400
-800
-67% -$75.8K ﹤0.01% 4290
2022
Q2 		$112K Sell
1,200
-3,200
-73% -$302K ﹤0.01% 4071
2022
Q1 		$516K Buy
+4,400
New +$510K ﹤0.01% 2890
2021
Q4 		– Sell
-1,400
Closed -$223K – 5323
2021
Q3 		$223K Buy
1,400
+200
+17% +$27.4K ﹤0.01% 3747
2021
Q2 		$158K Sell
1,200
-1,000
-45% -$133K ﹤0.01% 4102
2021
Q1 		$284K Buy
+2,200
New +$334K ﹤0.01% 3277

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Walleye Trading's ASND Position: Q3 2025 in Review

Walleye Trading sold out of Ascendis Pharma A/S (ASND) in Q3 2025, closing a stake of 2,605 shares — an estimated $486K sold.

Walleye Trading first reported a position in ASND in Q3 2024 and held it in 3 quarters. The position peaked at $3.12M in Q3 2024. 279 funds tracked by Wall St. Rank hold ASND as of Q3 2025.

  • Walleye Trading reported no remaining Ascendis Pharma A/S position as of Q3 2025 after selling out during the quarter.
  • Walleye Trading sold 2,605 Ascendis Pharma A/S shares in Q3 2025, an estimated $486K.
  • Walleye Trading first reported a position in Ascendis Pharma A/S in Q3 2024 and held it in 3 quarters.
  • Walleye Trading's Ascendis Pharma A/S position peaked at $3.12M in Q3 2024.
  • 279 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.